Market Place
Sourcing Support
Enhertu Adds Two More Breast Cancer Indications To Its US Label
16 May 2026 //
FDA
Candel Reports Long-Term Prostate Cancer Data Ahead of FDA Filing
16 May 2026 //
ENDPOINTS
Valion Bio Reports First Quarter 2026 Financial Results
15 May 2026 //
PR NEWSWIRE
Inhibrx Reports First Quarter 2026 Financial Results
15 May 2026 //
PR NEWSWIRE
Atrium Therapeutics Reports First Quarter 2026 Financial Results
15 May 2026 //
PR NEWSWIRE
Astrazeneca Follows Merck With Phase 3 Win In Bladder Cancer
15 May 2026 //
ENDPOINTS
Biogen`s Anti-Tau Drug Misses Phase 2, Shows Efficacy Signals
15 May 2026 //
BIOSPACE
Vyome Acquires Exclusive License For Selective JAK Inhibitor
15 May 2026 //
INDPHARMAPOST
FDA Approves Blood Cancer Drugs From Beone And Taiho
15 May 2026 //
REUTERS
Eli Lilly Introduces Lormalzi For Early Alzheimer`s Treatment
15 May 2026 //
INDPHARMAPOST
From Mscs To Ipscs: Building The Cell Therapy Future
14 May 2026 //
BIOSPACE
The Rise of GPCRs, Radiopharma & Peptide Screening
14 May 2026 //
BIOSPACE
Kyverna Therapeutics To Present At Upcoming Investor Conferences
14 May 2026 //
GLOBENEWSWIRE
Encoded`s Gene Therapy Reduced Seizures In Dravet Syndrome
14 May 2026 //
ENDPOINTS
Edesa Biotech Reports Fiscal 2Nd Quarter 2026 Results
14 May 2026 //
GLOBENEWSWIRE
Biodexa Issues Letter To Shareholders
14 May 2026 //
GLOBENEWSWIRE
Astrazeneca Follows Merck With Phase 3 Win In Bladder Cancer
14 May 2026 //
ENDPOINTS
AgomAb To Participate In Upcoming Conferences
14 May 2026 //
GLOBENEWSWIRE
Adaptin Bio Shares Commence Trading On The OTCQB
14 May 2026 //
GLOBENEWSWIRE
INOVIO Reports Q1 2026 Results and Recent Business Highlights
14 May 2026 //
PR NEWSWIRE
Armata Pharma Reports Q1 2026 Results And Corporate Update
14 May 2026 //
PR NEWSWIRE
Abeona Shifts Focus From Eye Therapies to Cancer
14 May 2026 //
FIRSTWORD PHARMA
METiS TechBio Debuts on Hong Kong Exchange
14 May 2026 //
PR NEWSWIRE
MacroGenics Unveils Q1 2026 Financials, Spotlights Business Shift
13 May 2026 //
GLOBENEWSWIRE
Biofrontera Second Annual Hats On for Actinic Keratosis Awareness
13 May 2026 //
GLOBENEWSWIRE
Opus Genetics To Present At RBC Global Healthcare Conference 2026
13 May 2026 //
GLOBENEWSWIRE
Dyne Therapeutics To Participate In Upcoming Investor Conferences
13 May 2026 //
GLOBENEWSWIRE
InnoCare Doses 1st Patient in Oral IL-17 Inhibitor Phase 1 Trial
13 May 2026 //
GLOBENEWSWIRE
Xenetic Biosciences Showcases Q1 2026 Financials, Advances Dnase
13 May 2026 //
ACCESSWIRE
Veru Unveils Q2 2026 Financials, Advances PLATEAU Trial Phase 2B
13 May 2026 //
GLOBENEWSWIRE
Milestone Pharma Reveals Q1 2026 Financials And Corporate Update
13 May 2026 //
GLOBENEWSWIRE
Protara Therapeutics Announces Q1 2026 Results & Business Update
13 May 2026 //
GLOBENEWSWIRE
Vtv Therapeutics Unveils Q1 2026 Financials And Corporate Update
13 May 2026 //
GLOBENEWSWIRE
Belite Bio Webcast On May 20, 2026 For Q1 2026 Financial Results
13 May 2026 //
GLOBENEWSWIRE
Wave Life Sciences to Present at 2026 RBC Global Healthcare Conf
13 May 2026 //
GLOBENEWSWIRE
Century Therapeutics Unveils Q1 Financials And Business Progress
13 May 2026 //
GLOBENEWSWIRE
Beam Therapeutics Backs Alphadetect For Faster Alpha-1 Detection
13 May 2026 //
PR NEWSWIRE
PDS Biotech`s Q1 2026 Results and Clinical and Corporate Updates
13 May 2026 //
GLOBENEWSWIRE
Allogene Therapeutics Ends China Cell Therapy Deal With Overland
13 May 2026 //
REUTERS
Zenas BioPharma Doses First Patient in Oral ZB021 Phase 1 Trial
13 May 2026 //
GLOBENEWSWIRE
Atea Pharma Showcases Viral Hepatitis Pipeline Progress At EASL
13 May 2026 //
GLOBENEWSWIRE
Sionna Therapeutics Joins 2026 RBC Global Healthcare Conference
13 May 2026 //
GLOBENEWSWIRE
Aprea Therapeutics Reports Q1 2026 Results and Corporate Update
13 May 2026 //
GLOBENEWSWIRE
Avalo Therapeutics Reveals Q1 2026 Financials & Business Update
13 May 2026 //
GLOBENEWSWIRE
Zenas Biopharma Unveils Q1 2026 Financials And Corporate Update
13 May 2026 //
GLOBENEWSWIRE
Bicara Therapeutics Grants Inducement Under Nasdaq Listing Rule
13 May 2026 //
GLOBENEWSWIRE
Equillium Unveils Q1 2026 Financials And Corporate Achievements
13 May 2026 //
GLOBENEWSWIRE
Altimmune Reports Q1 2026 Financial Results And Business Update
13 May 2026 //
GLOBENEWSWIRE
Behind Galapagos’ transformation into Lakefront Biotherapeutics
13 May 2026 //
ENDPOINTS
Candel Therapeutics To Present At Upcoming Investor Conferences
13 May 2026 //
GLOBENEWSWIRE
ZUSDURI Median Duration of Response Still Not Reached in Trial
13 May 2026 //
GLOBENEWSWIRE
Novo Nordisk Data Shows Wegovy Pill Achieves 21.6% Weight Loss
13 May 2026 //
GLOBENEWSWIRE
Polyrizon Secures First U.S. Clinical Site For NASARIX Allergy
13 May 2026 //
GLOBENEWSWIRE
PharmAla Biotech Forms Restora for APA-01 Clinical Development
13 May 2026 //
GLOBENEWSWIRE
Adjuvanted, High-Dose Flu Vaccines Equally Effective in Adults
13 May 2026 //
PRESS RELEASE
Briacell Enlists Penn Medicine For Phase 3 Breast Cancer Trial
13 May 2026 //
GLOBENEWSWIRE
Autoimmunity Biosolutions Boosts Seed Funding, Enhances Family
13 May 2026 //
PR NEWSWIRE
Allogene Therapeutics Reports Q1 2026 Results, Business Update
13 May 2026 //
GLOBENEWSWIRE
Biorestorative Therapies Unveils Source-Specific Exosome Data
13 May 2026 //
GLOBENEWSWIRE
ORYZON To Unveil Positive Iadademstat Data In AML At EHA 2026
13 May 2026 //
GLOBENEWSWIRE
